Two drugs used to treat osteoporosis may be better than either alone in maintaining bone density. Dr. Benjamin Leder and his colleagues at Massachusetts General Hospital found that combining ...

Scientists discover how bones “listen” to exercise and activate cellular signals that strengthen bone structure.

An experimental drug has successfully reduced hip and spine fractures in the two largest patient populations at risk for osteoporosis — postmenopausal women and men being treated for prostate cancer — ...

CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity and ...

The Food and Drug Administration on Tuesday approved an osteoporosis drug that represents the first new treatment approach in nearly two decades — a strategy based on a rare gene mutation in people ...

Researchers at Pompeu Fabra University (UPF) have made a great leap toward predicting the risk of hip fracture among people with osteoporosis and evaluating the effectiveness of specific drugs to ...

Osteoporosis is the most common bone disease in the U.S., leading to increased risk of fractures and a weakening of bone strength and structure. Now, new guidelines on who should be tested could lead ...

LOS ANGELES, Sept 19 (Reuters) - Amgen Inc's closely watched experimental osteoporosis drug significantly increased bone density in post-menopausal women through 48 months of treatment in a small ...

(HealthDay News) — For men with nonmetastatic prostate cancer who are receiving androgen deprivation therapy (ADT), bisphosphonates and denosumab improve bone mineral density (BMD), according to a ...